- Australia
- /
- Personal Products
- /
- ASX:MCP
McPherson's Full Year 2025 Earnings: AU$0.12 loss per share (vs AU$0.079 loss in FY 2024)
McPherson's (ASX:MCP) Full Year 2025 Results
Key Financial Results
- Revenue: AU$139.0m (down 3.9% from FY 2024).
- Net loss: AU$16.6m (loss widened by 46% from FY 2024).
- AU$0.12 loss per share (further deteriorated from AU$0.079 loss in FY 2024).
All figures shown in the chart above are for the trailing 12 month (TTM) period
McPherson's shares are down 15% from a week ago.
Risk Analysis
It is worth noting though that we have found 2 warning signs for McPherson's (1 makes us a bit uncomfortable!) that you need to take into consideration.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About ASX:MCP
McPherson's
Provides health, wellness, and beauty products in Australia, New Zealand, Asia, and internationally.
Excellent balance sheet and slightly overvalued.
Similar Companies
Market Insights
Community Narratives


